Allan Camaisa, Director at Calidi Biotherapeutics, Inc. (CLDI), sold 850 shares at $1.46 ($1K) on 2025-12-12, disclosed to the SEC on 2025-12-16.
Open-market sale of $1k CLDI by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.